By proceeding, you confirm that: We do not make any claims regarding the safety, efficacy, or suitability of these products for any specific use
Efforts to synthesise a more chemically stable analogue resulted in the drug liraglutide, a daily injection for diabetics released by Novo Nordisk in 2015
FDA regulations on peptides and compounding have an impact on semaglutides status, so patients should be aware of the risks associated with using it for weight loss
Watch for worsening depression, agitation, impulsive behavior, panic, unusual mood changes, or thoughts of self-harm
Of the people included in the study with type 2 diabetes, 17 naion events occurred in patients who were prescribed semaglutide, compared with six who were on other diabetes drugs
Currently, clinical trials are being conducted to evaluate the safety and efficacy of RG7388 in patients with various cancers 365,366 (Table 3)